Get the Stockscreener App
29.29
3.67%
-1.115
After Hours:
28.86
-0.43
-1.47%
Precipio Inc stock is traded at $29.29, with a volume of 36,684.
It is down -3.67% in the last 24 hours and up +27.79% over the past month.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
See More
Previous Close:
$30.41
Open:
$30.3
24h Volume:
36,684
Relative Volume:
0.46
Market Cap:
$52.43M
Revenue:
$25.83M
Net Income/Loss:
$-922.00K
P/E Ratio:
-56.77
EPS:
-0.5159
Net Cash Flow:
$555.00K
1W Performance:
-0.48%
1M Performance:
+27.79%
6M Performance:
+21.64%
1Y Performance:
+91.94%
1-Day Range:
$28.85
$30.39
1-Week Range:
$27.00
$32.57
52-Week Range:
$14.28
$33.63
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
4 SCIENCE PARK, NEW HAVEN, CT
Compare PRPO vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
29.29 | 52.69M | 25.83M | -922.00K | 555.00K | -0.5159 |
TMO
Thermo Fisher Scientific Inc
|
630.70 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.68 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
338.70 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
157.69 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
262.38 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
Precipio Inc Stock (PRPO) Latest News
Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong - TradingView
Precipio Inc (PRPO) (Q2 2026) Earnings Call Highlights: Record R - GuruFocus
Precipio (PRPO) Results Check: The Company Publishes Its Latest Results; Price Reaction: Shares Finish 1.53% Lower in the Available RecordEarnings Quality Analysis - vinanet.vn
Precipio Inc (PRPO) Stock Price, Trades & News - GuruFocus
Precipio, Inc. Q2 2026 Earnings: Revenue Beats $7.02 Million Record - Sci-Tech Today
Earnings call transcript: Precipio tops $7 million in Q2 2025 as growth turns profitable - Investing.com Australia
Precipio Announces Q2-2026 Financial Results - Knoxville News Sentinel
Q2 2026 Precipio Inc Earnings Call Transcript - GuruFocus
PRPO Looks 118.2% Overvalued on GF Value™ - GuruFocus
Precipio, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
(PRPO) Risk Channels and Responsive Allocation - Stock Traders Daily
Precipio 2Q Loss $200,000 >PRPO - moomoo.com
Is Precipio Inc (PRPO) Overvalued Despite Q2 Revenue of $7M? GF Score: 51/100, Valuation Discrepancy of 118.4% - GuruFocus
Precipio Posts Record Quarterly Revenue, Returns to Positive Adjusted EBITDA - Minichart
Form 8K Precipio Inc For: 14 August By Investing.com - Investing.com Australia
Precipio Q2 Revenue Hits Record $7.0 Million, Up 22% Year Over Year - Quiver Quantitative
Precipio posts record Q2 revenue $7.0M, returns to positive Adjusted EBITDA - TradingView
Precipio (PRPO) hits record Q2 revenue above $7M and returns to positive Adjusted EBITDA - Stock Titan
Precipio Q2 2026 Earnings Call Transcript - MarketBeat
Precipio Q2 Results: EPS turns to loss of $(0.12), sales up 24% - scanx.trade
Precipio, Inc. 2026: Revenue $7.02M, EPS ($0.12) — 10-Q Summary - TradingView
Cancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive - TradingView
Precipio, Inc. (PRPO) grows Q2 2026 revenue 24% amid going concern warning - Stock Titan
Precipio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Precipio (PRPO.US) will release its earnings report after market close on August 17. - Moomoo
Precipio Inc (PRPO) Stock News Today - TradingKey
Precipio Inc (NASDAQ: PRPO) Share Price, PRPO Stock News, PRPO Share Price & Updates - Kalkine
Precipio Inc (PRPO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Precipio (PRPO) Slips 3.81% to $22.70 as Diagnostics Stock Digests Recent RunETF Creation Redemption - vinanet.vn
(PRPO) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Precipio Schedules Q2 2026 Shareholder Update Call - The Globe and Mail
PRPO Q2 2025 Earnings: Positive EPS of $0.05 Highlights Profitability Progress Despite Share DeclineDividend Growth Analysis - vinanet.vn
PRPO Q2 2025 Earnings: Positive EPS Delivers Surprise Despite Lack of Consensus EstimatesProfitability Analysis - vinanet.vn
PRPO|Precipio Inc|Price:23.490|Chg%:-0.190 - TradingKey
Precipio Inc (PRPO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Precipio Inc (PRPO) Valuation: PE, PB & Fair Value Analysis - TradingKey
PRPO|Precipio Inc|Price:23.970|Chg%:+0.510 - tradingkey.com
Precipio Inc (PRPO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PRPO Q2 2025 Earnings: Return to Profitability with EPS of $0.05Negative Surprise Momentum - vinanet.vn
Precipio Inc (PRPO) Balance Sheet - TradingKey
Precipio Inc (PRPO) Institutional Confidence - TradingKey
Precipio Inc (PRPO) Income Statement - TradingKey
Precipio, Inc. Revenue Breakdown – NASDAQ:PRPO - TradingView
Precipio Announces Q1-2026 Shareholder Update Call - Moomoo
Precipio Inc (PRPO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Liquidity Mapping Around (PRPO) Price Events - Stock Traders Daily
PRPO Q2 2025 Earnings: Profitability Achieved Amid Revenue Disclosure GapsHealthcare Earnings Report - Vinanet
PRPO Q2 2025 Earnings: Positive EPS Surprise Amid Limited Revenue DisclosureFull Year Guidance - vinanet.vn
PRPO Q2 2025 Earnings: Company Posts Positive EPS Amid Limited Revenue DisclosureRevenue Estimate Trend - vinanet.vn
Precipio Inc. (PRPO) Edges Higher as Shares Test Key Resistance LevelTake Profit Levels - dars.gov.et
Form 4 Precipio Inc For: 16 July By Investing.com - Investing.com Nigeria
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Precipio Inc Stock (PRPO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SANDBERG RICHARD A | Director |
May 20 '26 |
Sale |
24.89 |
2,034 |
50,632 |
8,142 |
| SANDBERG RICHARD A | Director |
May 19 '26 |
Sale |
24.42 |
600 |
14,652 |
4,400 |
| SANDBERG RICHARD A | Director |
May 20 '26 |
Sale |
25.00 |
500 |
12,500 |
3,900 |
0.24%
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):